Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
Pediatric Studies Characteristics - Detail
FDA Home
Pediatrics
Pediatric Studies Characteristics
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Approval Date:
11/02/2010
Trade Name:
Ofirmev
Generic or Proper Name (*):
acetaminophen
Indications Studied:
Management of mild-to-moderate pain, for the management of moderate-to-severe pain with adjunctive opioid analgesics, and for the reduction of fever
Therapeutic Category:
Analgesic; Antipyretic
Ages Studied:
2 - 17 year olds
Study #:
4
Study Type:
Safety/Pharmacokinetic
Study Design:
Open label/Population Pharmacokinetic
No Patients:
81
No Centers:
5
No Countries:
1
BPCA(B), PREA(P):
P
-
-